SynthesisInternational journal of molecular sciences2022

Platelet-Rich Plasma as an Alternative to Xenogeneic Sera in Cell-Based Therapies: A Need for Standardization.

Eduardo Anitua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.